3649 results for «480»
3649 results
Closing remarks - PCR Innovators Day 2019
20 May 2019 – From PCR Innovators Day 2019
Consult this session to discover the closing remarks on PCR Innovators Day 2019, regarding the presentations of innovative technologies: Cavis Technologies' WireCath, CorFlow Therapeutics, Procerion and GENOSS.
EAPCI General Assembly
22 May 2019 – From EuroPCR 2019
Consult this session to discover the EAPCI General Assembly's slides, presented during EuroPCR 2019. Learn more about the different committees and the grants programme.
TAVI for aortic valve-in-valve - LIVE Case
22 May 2019 – From EuroPCR 2019
Consult this session to discover an exciting case, live transmitted during EuroPCR 2019: it will take you to a whole new territory of TAVI, focusing on the generation of bioprosthetic heart valves issues and the transcatheter solutions which are emerging as an optimal approach to this...
Treatment of bending zones in femoral and popliteal arteries - LIVE Case
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the different characteristics of devices and treatment strategies including: directional atherectomy + drug-coated balloon, calcified plaque softening with lithoplasty, new stents conforming to anatomy, and more!
LIVE demonstration from Clinique Pasteur - Toulouse, France
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Author
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Author
SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease
02 Nov 2022
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author